TR201619983A2 - Di̇klofenak ve eletri̇ptanin farmasöti̇k formülasyonlari - Google Patents
Di̇klofenak ve eletri̇ptanin farmasöti̇k formülasyonlari Download PDFInfo
- Publication number
- TR201619983A2 TR201619983A2 TR2016/19983A TR201619983A TR201619983A2 TR 201619983 A2 TR201619983 A2 TR 201619983A2 TR 2016/19983 A TR2016/19983 A TR 2016/19983A TR 201619983 A TR201619983 A TR 201619983A TR 201619983 A2 TR201619983 A2 TR 201619983A2
- Authority
- TR
- Turkey
- Prior art keywords
- eletriptan
- diclofenac
- pharmaceutical formulations
- pharmaceutically acceptable
- acceptable salt
- Prior art date
Links
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 title abstract 2
- 229960001259 diclofenac Drugs 0.000 title abstract 2
- OTLDLQZJRFYOJR-LJQANCHMSA-N eletriptan Chemical compound CN1CCC[C@@H]1CC1=CN=C2[C]1C=C(CCS(=O)(=O)C=1C=CC=CC=1)C=C2 OTLDLQZJRFYOJR-LJQANCHMSA-N 0.000 title abstract 2
- 229960002472 eletriptan Drugs 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Mevcut buluş diklofenak veya farmasötik olarak kabul edilebilir bir tuzunun eletriptan veya farmasötik olarak kabul edilebilir bir tuzuyla kombinasyonunu ve en az bir farmasötik olarak kabul edilebilir yardımcı madde içeren bir farmasötik kompozisyonla ilgilidir.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2016/19983A TR201619983A2 (tr) | 2016-12-29 | 2016-12-29 | Di̇klofenak ve eletri̇ptanin farmasöti̇k formülasyonlari |
EP17210906.8A EP3342404A1 (en) | 2016-12-29 | 2017-12-28 | Pharmaceutical compositions of diclofenac and eletriptan |
PCT/EP2017/084742 WO2018122330A1 (en) | 2016-12-29 | 2017-12-28 | Pharmaceutical compositions of diclofenac and eletriptan |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2016/19983A TR201619983A2 (tr) | 2016-12-29 | 2016-12-29 | Di̇klofenak ve eletri̇ptanin farmasöti̇k formülasyonlari |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201619983A2 true TR201619983A2 (tr) | 2018-07-23 |
Family
ID=60813750
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2016/19983A TR201619983A2 (tr) | 2016-12-29 | 2016-12-29 | Di̇klofenak ve eletri̇ptanin farmasöti̇k formülasyonlari |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP3342404A1 (tr) |
TR (1) | TR201619983A2 (tr) |
WO (1) | WO2018122330A1 (tr) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3558690A (en) | 1965-04-08 | 1971-01-26 | Gelgy Chemical Corp | Substituted derivatives of 2-anilinophenylacetic acids and a process of preparation |
HUT64326A (en) | 1990-10-15 | 1993-12-28 | Pfizer | Process for production indole derivatives and pharmaceutical preparations containing these compounds |
JP2009535336A (ja) * | 2006-04-25 | 2009-10-01 | コーワ ファーマシューティカルズ アメリカ,インコーポレイティド | 片頭痛治療用の固定組合せ剤形 |
US8618157B2 (en) | 2008-06-20 | 2013-12-31 | Alphapharm Pty. Ltd. | Pharmaceutical formulation |
-
2016
- 2016-12-29 TR TR2016/19983A patent/TR201619983A2/tr unknown
-
2017
- 2017-12-28 EP EP17210906.8A patent/EP3342404A1/en not_active Withdrawn
- 2017-12-28 WO PCT/EP2017/084742 patent/WO2018122330A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2018122330A1 (en) | 2018-07-05 |
EP3342404A1 (en) | 2018-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY196173A (en) | Cot Modulators And Methods Of Use Thereof | |
BR112015020466A8 (pt) | inibidores de cdc7, seus usos, e composição farmacêutica | |
NZ734233A (en) | Pharmaceutical compositions comprising meloxicam | |
CO2017013293A2 (es) | Formulaciones farmacéuticas que comprenden tenofovir y emtricitabina | |
SG10201810985XA (en) | Tofacitinib oral sustained release dosage forms | |
CL2016001424A1 (es) | Composiciones de liberación retardada de lionaclotida | |
CL2015002733A1 (es) | Composición farmacéutica de clorhidrato de s-cetamina. | |
BR112017028140A2 (pt) | formulações farmacêuticas | |
EA202090683A3 (ru) | Способы и композиции для лечения рака | |
CO2019008103A2 (es) | Composiciones farmacéuticas para terapia de combinación | |
MA41159A (fr) | Octréotide destiné à être administré par voie orale en association avec d'autres agents thérapeutiques | |
GT201700124A (es) | Formulación de relación fija de insulina glargina/lixisenatida | |
EA201690679A1 (ru) | Стабильная фармацевтическая композиция, содержащая амлодипин и валсартан | |
DOP2016000297A (es) | Composiciones farmacéuticas útiles para tratar enfermedades infecciosas | |
EA201991287A1 (ru) | Твердые фармацевтические композиции на основе тикагрелора для перорального применения | |
ECSP16086232A (es) | (r) -pirlindole y sus sales farmacéuticamente aceptables para uso en medicina | |
MX2021003230A (es) | Composiciones farmaceuticas que comprenden meloxicam. | |
NZ713440A (en) | Nsaid administration and related compositions, methods and systems. | |
BR112017024126B8 (pt) | Composições farmacêuticas, composto a micronizado e/ou pelo menos um sal farmaceuticamente aceitável micronizado do composto a e uso dos mesmos | |
TR201821114A2 (tr) | Erdostei̇n i̇çeren efervesan farmasöti̇k bi̇leşi̇m | |
TR201721700A2 (tr) | Saksagli̇pti̇ni̇n ağizda dağilan formülasyonlari | |
AR106415A1 (es) | Composición farmacéutica para el tratamiento del dolor | |
TR201619983A2 (tr) | Di̇klofenak ve eletri̇ptanin farmasöti̇k formülasyonlari | |
BR112017014295A2 (pt) | composição farmacêutica. | |
EA201991007A1 (ru) | Твердые фармацевтические композиции на основе гидрохлорида луразидона для перорального применения |